{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:41:17Z","timestamp":1774791677470,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","id.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.idc.2014.08.006","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T05:07:15Z","timestamp":1416460035000},"page":"585-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Barrier Methods for Human Immunodeficiency Virus Prevention"],"prefix":"10.1016","volume":"28","author":[{"given":"Ellen F.","family":"Eaton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig J.","family":"Hoesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.idc.2014.08.006_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jama.300.5.520","article-title":"Estimation of HIV incidence in the United States","volume":"300","author":"Hall","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003255","article-title":"Condom effectiveness in reducing heterosexual HIV transmission","author":"Weller","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.idc.2014.08.006_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00007435-199904000-00006","article-title":"Implications of laboratory tests of condom integrity","volume":"26","author":"Carey","year":"1999","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.idc.2014.08.006_bib4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0277-9536(96)00258-4","article-title":"Effectiveness of condoms in preventing HIV transmission","volume":"44","author":"Pinkerton","year":"1997","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.idc.2014.08.006_bib5","first-page":"454","article-title":"Effectiveness of condoms in preventing sexually transmitted infections","volume":"82","author":"Holmes","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.idc.2014.08.006_bib6","first-page":"589","article-title":"Update: barrier protection against HIV and other sexually transmitted diseases","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.idc.2014.08.006_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1473-3099(09)70021-0","article-title":"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies","volume":"9","author":"Boily","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2014.08.006_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/jir747","article-title":"Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples","volume":"205","author":"Hughes","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2014.08.006_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2307\/2135469","article-title":"Family planning, sexually transmitted diseases, and contraceptive choice: a literature update","volume":"24","author":"Cates","year":"1992","journal-title":"Fam Plann Perspect"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11904-012-0143-7","article-title":"State of condom use in HIV prevention science and practice","volume":"10","author":"Crosby","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2196\/jmir.2301","article-title":"Mobile phone applications for the care and prevention of HIV and other sexually transmitted diseases: a review","volume":"15","author":"Muessig","year":"2013","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.idc.2014.08.006_bib12","unstructured":"Palmer K. The real cost of birth control. US News World Rep. 2010. Available at: http:\/\/money.usnews.com\/money\/blogs\/alpha-consumer\/2010\/08\/27\/the-real-cost-of-birth-control. Accessed February 5, 2014."},{"issue":"Suppl 5","key":"10.1016\/j.idc.2014.08.006_bib13","first-page":"362","article-title":"Condom use during most recent vaginal intercourse event among a probability sample of adults in the United States","volume":"7","author":"Sanders","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1071\/SH11095","article-title":"Condom use errors and problems: a global view","volume":"9","author":"Sanders","year":"2012","journal-title":"Sex Health"},{"key":"10.1016\/j.idc.2014.08.006_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0010-7824(92)90137-I","article-title":"Condom performance during vaginal intercourse: comparison of Trojan-Enz (trademark) and Tactylon (trademark) condoms","volume":"45","author":"Trussell","year":"1992","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.idc.2014.08.006_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/aje\/kwm300","article-title":"Problems with condom use among patients attending sexually transmitted disease clinics: prevalence, predictors, and relation to incident gonorrhea and chlamydia","volume":"167","author":"Warner","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.idc.2014.08.006_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11904-012-0114-z","article-title":"HIV-1 prevention for HIV-1 serodiscordant couples","volume":"9","author":"Curran","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"10.1016\/j.idc.2014.08.006_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2105\/AJPH.2007.120337","article-title":"Evaluation of an HIV prevention intervention adapted for black men who have sex with men","volume":"98","author":"Jones","year":"2008","journal-title":"Am J Public Health"},{"issue":"40","key":"10.1016\/j.idc.2014.08.006_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0968-8080(12)40659-0","article-title":"New female condoms in the pipeline","volume":"20","author":"Beksinska","year":"2012","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.idc.2014.08.006_bib20","unstructured":"The WHO\/UNFPA Female Condom Technical Review Committee. Department of reproductive health and research. Report on FC2. Available at: http:\/\/whqlibdoc.who.int\/hq\/2007\/WHO_RHR_07.18_eng.pdf?ua=1. Accessed January 25, 2014."},{"issue":"12","key":"10.1016\/j.idc.2014.08.006_bib21","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2105\/AJPH.2011.300260","article-title":"Off-label use of the female condom for anal intercourse among men in New York City","volume":"101","author":"Kelvin","year":"2011","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.idc.2014.08.006_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2004.08.008","article-title":"Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial","volume":"71","author":"Galv\u00e3o","year":"2005","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/aje\/kwm046","article-title":"Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial","volume":"166","author":"Macaluso","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.idc.2014.08.006_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00007435-200305000-00010","article-title":"Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women","volume":"30","author":"French","year":"2003","journal-title":"Sex Transm Dis"},{"issue":"10","key":"10.1016\/j.idc.2014.08.006_bib25","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1258\/095646206780071036","article-title":"A\u00a0review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence","volume":"17","author":"Vijayakumar","year":"2006","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.idc.2014.08.006_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.contraception.2005.07.015","article-title":"Performance of the reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women","volume":"73","author":"Beksinska","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.idc.2014.08.006_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.contraception.2005.10.019","article-title":"Short-term acceptability of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women","volume":"73","author":"Smit","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.idc.2014.08.006_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.contraception.2010.08.002","article-title":"Three new female condoms: which do South-African women prefer?","volume":"83","author":"Joanis","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.idc.2014.08.006_bib29","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S2214-109X(13)70054-8","article-title":"Performance and safety of the second-generation female condom (FC2) versus the Woman's, the VA worn-of-women, and the Cupid female condoms: a randomised controlled non-inferiority crossover trial","volume":"1","author":"Beksinska","year":"2013","journal-title":"Lancet Glob Health"},{"issue":"10","key":"10.1016\/j.idc.2014.08.006_bib30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/QAD.0b013e32835462b8","article-title":"Prevention of sexual transmission of HIV: real results, science progressing, societies remaining behind","volume":"26","author":"Laga","year":"2012","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.idc.2014.08.006_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2307\/2648163","article-title":"Female condom use among women at high risk of sexually transmitted disease","volume":"32","author":"Macaluso","year":"2000","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.idc.2014.08.006_bib32","unstructured":"Belluck P. Getting men to want to use condoms. NYT.com. 2013. Available at: http:\/\/well.blogs.nytimes.com. Accessed February 22, 2014."},{"key":"10.1016\/j.idc.2014.08.006_bib33","unstructured":"Bill and Melinda Gates Foundation. Gates Foundation awards grants to test ideas ranging from using big data for social good to inventing the next generation of condoms. Grandchallenges.org. 2013. Available at: http:\/\/www.grandchallenges.org\/. Accessed February 22, 2014."},{"issue":"5","key":"10.1016\/j.idc.2014.08.006_bib34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0015-0282(16)55038-9","article-title":"The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques","volume":"57","author":"Miller","year":"1992","journal-title":"Fertil Steril"},{"issue":"9338","key":"10.1016\/j.idc.2014.08.006_bib35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","article-title":"Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial","volume":"360","author":"Van Damme","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.idc.2014.08.006_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00042560-199804010-00006","article-title":"Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects","volume":"17","author":"Stafford","year":"1998","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"6","key":"10.1016\/j.idc.2014.08.006_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/AAC.41.6.1335","article-title":"The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in\u00a0vitro","volume":"41","author":"Wyrick","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2014.08.006_bib38","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1371\/journal.pone.0001312","article-title":"SAVVY (C31G) gel for prevention of HIV infection in women: a phase 3, double blind, randomized, placebo-controlled trial in Ghana","volume":"2","author":"Peterson","year":"2007","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib39","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1371\/journal.pone.0001474","article-title":"SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria","volume":"3","author":"Feldblum","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.contraception.2009.07.002","article-title":"A\u00a0randomized, double-blind, placebo-controlled phase II extended safety study of two invisible condom formulations in Cameroonian women","volume":"81","author":"Mbopi-Keou","year":"2010","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.idc.2014.08.006_bib41","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1086\/315127","article-title":"Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition","volume":"180","author":"Martin","year":"1999","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2014.08.006_bib42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","article-title":"Safety and effectiveness of buffergel and 0.5% PRO2000 gel for the prevention of HIV infection in women","volume":"25","author":"Abdool Karim","year":"2011","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.idc.2014.08.006_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0010-7824(99)00102-X","article-title":"Study of the vaginal tolerance to acidiform, an acid-buffering, bioadhesive gel","volume":"60","author":"Amaral","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.idc.2014.08.006_bib44","first-page":"648","article-title":"Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus","volume":"4","author":"Lagenaur","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/498533","article-title":"PRO2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial","volume":"193","author":"Keller","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2014.08.006_bib46","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1095\/biolreprod.102.014555","article-title":"Carageenan formulation prevents macrophage trafficking from vagina: implications for microbicide development","volume":"69","author":"Perotti","year":"2003","journal-title":"Biol Reprod"},{"issue":"9654","key":"10.1016\/j.idc.2014.08.006_bib47","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of carraguard for prevention of HIV infection in women in South Africa: a randomized, double-blind, placebo-controlled trial","volume":"372","author":"Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.idc.2014.08.006_bib48","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1128\/AAC.49.9.3607-3615.2005","article-title":"Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action","volume":"49","author":"Scordi-Bello","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2014.08.006_bib49","doi-asserted-by":"crossref","first-page":"e3784","DOI":"10.1371\/journal.pone.0003784","article-title":"Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a phase III trial in Nigeria","volume":"3","author":"Halpern","year":"2008","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.idc.2014.08.006_bib50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/655661","article-title":"Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor","volume":"202","author":"Veazey","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2014.08.006_bib51","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/598685","article-title":"Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian immunodeficiency virus challenge","volume":"199","author":"Veazey","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2014.08.006_bib52","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.idc.2014.08.006_bib53","unstructured":"Microbicide Trials Network. MTN statement on decision to discontinue use of tenofovir gel in VOICE, a major HIV prevention study in women. 2011. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00705679. Accessed February 5, 2014."},{"issue":"7","key":"10.1016\/j.idc.2014.08.006_bib54","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","article-title":"Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention","volume":"26","author":"Van der Straten","year":"2012","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.idc.2014.08.006_bib55","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/QAD.0b013e32832c413d","article-title":"Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women","volume":"23","author":"Nel","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2014.08.006_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/aid.2008.0184","article-title":"Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring","volume":"25","author":"Romano","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.48.1.337-339.2004","article-title":"In\u00a0vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides","volume":"48","author":"Van Herrewege","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2014.08.006_bib58","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1128\/JVI.02422-10","article-title":"The nonnucleoside reverse transcriptase inhibitor MIV-150 in carageenan gel prevents rectal transmission of simian\/human\u00a0immunodeficiency virus infection in macaques","volume":"85","author":"Singer","year":"2011","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.idc.2014.08.006_bib59","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1128\/AAC.05461-11","article-title":"Zinc acetate\/carrageenan gels exhibit potent activity in\u00a0vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge","volume":"56","author":"Fernandez-Romero","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"S1","key":"10.1016\/j.idc.2014.08.006_bib60","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s10461-011-9901-6","article-title":"Sexual health, HIV, and sexually transmitted infections among gay, bisexual, and other men who have sex with men in the United States","volume":"15","author":"Wolitski","year":"2011","journal-title":"AIDS Behav"},{"issue":"4","key":"10.1016\/j.idc.2014.08.006_bib61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/OLQ.0b013e3181901ccf","article-title":"Anal intercourse among heterosexuals in three sexually transmitted disease clinics in the Unites States","volume":"36","author":"Gorbach","year":"2009","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.idc.2014.08.006_bib62","doi-asserted-by":"crossref","first-page":"e23243","DOI":"10.1371\/journal.pone.0023243","article-title":"First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex\u00a0vivo efficacy","volume":"6","author":"Anton","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.idc.2014.08.006_bib63","doi-asserted-by":"crossref","first-page":"e60147","DOI":"10.1371\/journal.pone.0060147","article-title":"A\u00a0phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007)","volume":"8","author":"McGowan","year":"2013","journal-title":"PLoS One"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552014000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552014000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T12:10:34Z","timestamp":1566043834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552014000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0891552014000592"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2014.08.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barrier Methods for Human Immunodeficiency Virus Prevention","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2014.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}